Developed a go-to-market plan for a spatial biology startup company along with 7 other team members

In the lab of Dr. Joseph St. Geme III in the Children's Hospital of Philadelphia, studying bacterial pathogenesis and vaccine development of the pediatric pathogen, Kingella kingae- Analyze elaborate scientific data to understand experimental outcomes and draw conclusions from experiments, resulting in the drafting of two manuscripts to be submitted to peer-reviewed journals- Communicate complex scientific principles to varying audiences (professional conferences, key microbiology investigators, high school students) through oral presentations, PowerPoint slide decks, and data figures- Reviewed literature on Kingella kingae bacterial pathogenesis and condensed research findings into a peer-reviewed publication- Supervised 2 junior graduate students for a semester each, educating them on scientific techniques, research strategies, and science communication- Develop novel protocols for answering scientific questions regarding K. kingae immune evasion and vaccine development

- Conducted landscape analysis for a non-profit agency intending to fund labs and companies developing novel adenoviral and adeno-associated virus (AAV) vector gene therapies for the treatment of cystic fibrosis- Analyzed clinical trial data of key companies and reviewed patents of relevant technologies to identify top companies for client investment- Contacted and interviewed Key Opinion Leaders (KOLs) to gather insight on top adenoviral gene therapies for cystic fibrosis- Interpreted and translated data and scientific complex concepts into relevant communications to the client regarding the current immune response challenges to adenovirus and AAV vectors- Provided recommendations of key companies / platforms to target for funding

- Participated on a team of 12 graduate students under the guidance of project managers as a pro bono consultant for a biotech company to ensure timely and satisfactory deliverables- Performed market research, reviewed clinical trial and patent data, and conducted scientific literature review to identify candidates for synergistic acquisition by the biotech company- Assembled detailed final reports and spreadsheets on relevant technologies- Delivered midterm and final presentations to key client members informing final recommendations- Awarded Best Team Member Award – recognizes those whose efforts resulted in a high level of teamproductivity

- Penn INSPIRE is a trainee-led coalition at Penn advocating for scientists and physicians historically marginalized and excluded in STEM across all degree and professional levels- Coordinated seminars and workshops for invited speakers- Broadcasted event invitations via social media platforms

Screened a panel of wildlife strains of Listeria species isolated from black bears for antibiotic resistance, gene transferability, and virulence potential, resulting in a published co-first author peer-reviewed manuscript.

Burleson Research Technologies, Inc. (BRT) is a contract research organization serving the pharmaceutical, biotech, and chemical industries with specialized services in immunopharmacology, immunotoxicology, and infectious disease studies.-Responsible for assisting laboratory and vivarium staff in a variety of procedures that are instrumental in evaluating the effectiveness or toxicity of new pharmaceutical drug candidates.-Exposed to in-vivo - immunopharmacology/immunotoxicology research studies on rodents, as well as ex-vivo procedures and assays such as ELISA, Elispot, and NK, CTL, and complement assays-Involved in animal handling, husbandry, dosing, and blood collection procedures-Observe and assist with necropsies, tissue processing, and complex experiments that are performed to evaluate the effects of test compounds on the immune system.